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Abstract
Background: Following voxel-based morphometry (VBM), brain-derived neurotrophic factor (BDNF) Val66Met polymor-
phism (rs6265) has been shown to affect human brain morphology in Caucasians. However, little is known about the
specific role of the Met/Met genotype on brain structure. Moreover, the relationship between BDNF Val66Met
polymorphism and Chinese brain morphology has not been studied.
Methodology/Principal Findings: The present study investigated brain structural differences among three genotypes of
BDNF (rs6265) for the first time in healthy young Chinese adults via cortical thickness analysis and VBM. Brain differences in
Met carriers using another grouping method (combining Val/Met and Met/Met genotypes into a group of Met carriers as in
most previous studies) were also investigated using VBM. Dual-approach analysis revealed less gray matter (GM) in the
frontal, temporal, cingulate and insular cortices in the Met/Met group compared with the Val/Val group (corrected, P,0.05).
Areas with less GM in the Val/Met group were included in the Met/Met group. VBM differences in Met carriers were only
found in the middle cingulate cortex.
Conclusions/Significance: The current results indicated a unique pattern of brain morphologic differences caused by BDNF
(rs6265) in young Chinese adults, in which the Met/Met genotype markedly affected the frontal, temporal, cingulate, and
insular regions. The grouping method with Met carriers was not suitable to detect the genetic effect of BDNF Val66Met
polymorphism on brain morphology, at least in the Chinese population, because it may hide some specific roles of Met/Met
and Val/Met genotypes on brain structure.
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Introduction
With the rise of imaging genomics, more and more studies have
demonstrated that brain structure and function are under strong
genetic control [1]. As a strong candidate gene that could influence
brain development and function, brain-derived neurotrophic
factor (BDNF) is involved in regulating neuronal survival,
proliferation and differentiation, as well as synaptic plasticity
processes [2,3]. A common single nucleotide polymorphism in the
human BDNF gene (rs6265) leading to a substitution of
methionine (Met) for valine (Val) at codon 66 in the pro-region
of the BDNF protein (Val66Met) could result in disruption of
activity-dependent BDNF secretion [4,5]. In recent years,
structural magnetic resonance imaging (MRI) scans have revealed
that the BDNF Val66Met polymorphism can influence human
brain morphology. The Met allele carriers showed less gray matter
(GM) volume in some brain areas, such as the hippocampus [6,7],
subgenual anterior cingulated [8], dorsolateral prefrontal cortex
(DLPFC) [7,9], amygdale [10], and temporal and occipital lobar
regions [11], compared with Val/Val homozygotes. However,
these previous studies have provided little information on
individuals who are homozygous for the Met allele (Met/Met)
because of its small frequency in Caucasians. The Met/Met
genotype is rare and is found only about 4% (Met allele frequency:
20% to 30%) of the Caucasian populations [4,12], which results in
rigorous demand on sample size when obtaining information on
only Met homozygotes in this race. As a result, the Met/Met
homozygotes and the Val/Met heterozygotes were often merged
into a group of Met carriers for analyses in most of these studies,
which undoubtedly limited the detection of the specific role of the
Met/Met genotype on brain structure.
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e37777Compared to the Caucasian populations, Asians have a higher
Met allele frequency, namely more than 40% [12,13]. In addition,
20–30% of the Met/Met homozygote distribution and nearly 50%
of the Met allele frequency exist in the Chinese population [14,15],
which allows analysis of the Met/Met genotype alone to be
conducted more readily. To date, data with regards to the
relationship between BDNF (rs6265) genotypes and brain
structure in the Chinese population is lacking. Moreover, some
physiological processes related to BDNF (rs6265) have already
been linked racial differences, such as mental diseases in which an
association between the Val66Met polymorphism and schizophre-
nia exists in Scottish, Spanish and American individuals
[16,17,18], unlike the Chinese population [14]. Thus, whether
or not the influence of the genetic variant of BDNF (rs6265) on
brain anatomy also varies among races is worth discussion. A
large-scale general population study on this problem is necessary.
In addition, to our knowledge (online search in PubMed,
http://www.ncbi.nlm.nih. gov/pubmed ), most studies measuring
structural brain differences among BDNF(rs6265) genotypes were
based on GM volume using voxel-based morphometry (VBM).
VBM is a good automatic method to assess volumetric differences
over the whole brain. This method offers information on GM
volume from cortical and subcortical areas by combining all
structure properties (thickness, surface area, and folding), however,
these properties are essentially independent from each other.
Compared with VBM, the method of cortical thickness measure-
ment provides a direct examination on thickness independent of
surface or position variance, and allows for better matching of
homologous cortical regions using geometry to do inter-subject
registration [19,20,21]. If these two methods are used toghther, the
results driven by dual-analysis would be more credible [22,23].
However, few studies have focused on the relevance of cortical
thickness to the BDNF Val66Met polymorphism. Despite a study
reporting no relevance of cortical thickness with the rs6265
genotypes [24], a few recent studies have shown that BDNF
(rs6265) contributed to the cortical thickness changes in the
entorhinal cortex, temporal gyri and DLPFC [25,26] in people at
risk of developing Alzheimer’s disease or suffering from trauma.
However, it remains unclear whether the cortical thickness in
other brain areas was also affected by the BDNF Val66Met
polymorphism in healthy subjects.
Therefore, in order to understand the impact of different
genotypes of BDNF Val66Met polymorphism on brain structural
plasticity, the present study combined for the first time cortical
thickness analysis and VBM to investigate the structural brain
differences among three BDNF Val66Met genotypes (Val/Val,
Val/Met and Met/Met) in healthy young Chinese adults.
Moreover, we also observed differences in brain anatomy in Met
allele carriers by merging the Val/Met with Met/Met groups, as
performed in previous studies, to evaluate the differences caused
by grouping methods.
Results
Allele and Genotype Distribution
Thirteen individuals did not participate in the MRI scanning
because of quitting, and the MRI data of 7 participants was
discarded because of unsuccessful DNA sequencing or MRI
scanning. Therefore, 61 subjects in total were finally grouped
according to their BDNF genotype, into 15 homozygous carriers
of the Val allele (Val/Val), 17 homozygous carriers of the Met
allele (Met/Met), and 29 heterozygous (Val/Met). The frequency
of the BDNF genotypes was 24.6% for Val/Val, 47.5% for Val/
Met, and 27.9% for Met/Met in our study of sample (Table 1),
which was similar to previously published results based on the
Chinese population [14,27,28]. The distribution of genotypes in
healthy subjects was consistent with the Hardy–Weinberg
Equilibrium (x
2=0.141, P=0.707). There were no significant
differences between males and females with respect to genotype
(x
2=4.077, P=0.13) and allele distribution (x
2=3.175,
P=0.075).
Cortical Thickness Differences between Val/Met, Met/Met
and Val/Val Genotypes
In general, compared to homozygous Val carriers there were no
brain regions showing thickening in homozygous Met or
heterozygous Met carriers. Compared with the Val/Val group,
both the Met/Met and Val/Met groups exhibited a significantly
thinner cortex in the frontal (superior, middle and orbital parts)
cortex, middle temporal cortex (MTC), superior parietal cortex
(SPC), lateral occipital cortex (LOC), insular cortex (IC) and
precuneus cortex (PC) in one or both hemispheres (FDR
corrected, P,0.05; Figure 1, Table 2 and 3). Moreover, the
Met/Met group was observed to have reduced thickness in other
areas, including the left inferior parietal cortex (IPC), and the
posterior cingulate cortex (PCC) (FDR corrected, P,0.05; Figure 1
and Table 2).
VBM Differences between Val/Met, Met/Met and Val/Val
Genotypes
Although numerous studies have investigated the relevance
between the BDNF Val66Met polymorphism and GM volume, no
study has focused on the Chinese population. In this study we
observed GM volume differences among BDNF (rs6265) geno-
types in young Chinese adults.
No brain regions showed increased GM volume in the Met
variant, and the total GM volume over the entire brain was not
different among groups. Compared to the Val/Val group, Met/
Met individuals had a smaller volume in some areas of the frontal,
temporal, cingulate and insular cortices in one or both
hemispheres (Figure 2, TFCE corrected, P,0.05). For Val/Met
subjects, the left middle cingulate cortex (MCC) and IC showed
smaller volumes relative to people who were homozygous for the
Val allele (TFCE corrected, P,0.05; Figure 2).
When grouping Met/Met and Val/Met genotypes as a group of
Met carriers, as performed in many prior studies, the Met carriers
possessed a smaller GM volume only in the bilateral MCC (TFCE
corrected, P,0.05; Figure 2).
Discussion
BDNF is a key regulator of synaptic plasticity. A critical
polymorphism at codon 66 of the BDNF amino acid sequence can
result in brain anatomy alteration, which was proven by numerous
Table 1. Genotype and allele frequencies of the BDNF
Val66Met polymorphism in healthy young Chinese adults.
Genotype (%) Allele (%)
Val/Val Val/Met Met/Met Val Met
Male n=34 5 18 11 28 40
Female n=27 10 11 6 31 23
Total n=61 15(24.6) 29(47.5) 17(27.9) 59(48.4) 63(51.6)
doi:10.1371/journal.pone.0037777.t001
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The present study is the first to report patterns of cortical thinning
and GM loss in healthy young Chinese adults among BDNF
Val66Met genotypes, and the specific role of the Met/Met
genotype was evaluated in detail for the first time by combining
cortical thickness analysis and VBM, in virtue of a higher
frequency of the Met/Met genotype (27.9%) distributed in our
present sample. The present study showed that the brain
morphology difference in Chinese people carrying the Met allele
did display different patterns from Caucasian individuals. In
Caucasian people, the difference in brain structure in Met carriers
mainly came from Val/Met individuals, because only a few Met/
Met subjects were among the Met carriers [11,31]. However, in
our study the Met/Met and Val/Met individuals both showed
significant anatomy differences from Val/Val individuals, but the
Met carriers (combining Met/Met and Val/Met genotypes)
showed the least difference in brain structure. Moreover, the
differences in some brain areas were not shared between
Caucasians and Chinese, such as the hippocampus which showed
a small GM volume in some previous studies based on Caucasians
[4,7,32] but no difference among BDNF genotypes in our current
study. In addition, some regions that were not mentioned in
previous Caucasian studies showed anatomical differences among
BDNF genotypes in our study. Ethnicity may be a reason for the
different effects of BDNF (rs6265) polymorphism in Caucasians
and Chinese.
Brain Structural Difference in Met/Met Genotype Subjects
Following comparison of Met/Met and Val/Val genotypes,
consistent differences in cortical thickness and GM volume were
found in the present study, particularly in the OFC, MTC, PCC,
and IC which showed decreased cortical thickness and GM
volume in the Met/Met group. These matching results suggested
that these frontal, temporal, cingulate, and insular regions were
probably the key areas in which brain structure was determined by
BDNF 66Met to some extent in Chinese people.
To date, there has been no study reporting brain structural
differences in the BDNF (rs6265) Met/Met genotype alone. The
current study was the first to report the effect of the Met/Met
genotype on brain morphology using cortical thickness analysis
and VBM. Some of our VBM results were consistent with previous
studies which were based on Met carriers (combining Val/Met
and Met/Met) who had reduced GM volume in the frontal
[7,9,33] and temporal cortices [11]. Although the Met carriers in
these studies were mainly of the Val/Met genotype, together with
our VBM and cortical thickness analysis, we believe that the Met
allele of BDNF (rs6265) most likely influences brain morphology
and that the Met/Met genotype causes the most significant effects,
at least in young Chinese adults.
The cortical thickness and VBM analysis also demonstrated
GM differences in several other regions of Met/Met subjects,
including the superior frontal cortex (SFC), middle frontal cortex
(MFC), IPC, SPC, PC, and LOC with reduced cortical thickness,
and the IFC, ACC, MCC and ITC with decreased GM volume.
The differences in cortical thickness and GM volume in most of
these regions were consistent with previous VBM studies
[7,9,11,33]excepting the MCC which has never been reported
until now. Anatomical studies have showen that the IC has
extensive connections with the frontal, parietal, temporal and
cingulate cortices [34,35,36,37], which showed reduced GM in
our present study no matter the cortical thickness or GM volume.
Therefore, this interactive fibers relationship may be directly or
indirectly contributed to the GM differences in the MCC, PCC,
parietal lobe and IC in Met homozygotes of our present study.
However, because VBM and cortical thickness results in some of
these regions were not consistent in the present study, the
correlation of the BDNF (rs6265) Met/Met genotype and brain
anatomical differences in these areas requires further clarification.
Brain Structural Differences in Val/Met Genotype
Subjects
Regarding the comparison of the Val/Met and Val/Val
genotypes, matching results were found in the IC by dual-analysis,
which were also shown in the comparision between Met/Met and
Val/Val groups. These results suggested that this area was most
likely influenced by BDNF (rs6265) polymorphism. In addition,
decreased GM volume was also found in the MCC in the Val/Met
group, and was also observed in the Met/Met group. In addition,
reduced cortical thickness in the Val/Met group was found in
other areas including the OFC, MFC, SFC, MTC, SPC, PC and
LOC which were also included within the cortical thickness
decreased regions of the Met/Met group when compared to the
Val/Val group. Thus, it can be seen that regions showing
differences in Met-heterozygotes overlapped with those of Met-
homozygotes. It suggested that substitution of the Met allele for the
Val allele in the two homologous chromosomes of the BDNF DNA
Figure 1. Cortical thickness differences among three genotypes based on the BDNF Val66Met polymorphism. Left panel: areas with a
significantly thinning cortex in the Met/Met group compared with the Val/Val group (Met/Met , Val/Val, corrected, P,0.05). Right panel: areas with a
significantly thinning cortex in the Val/Met group compared with the Val/Val group (Val/Met , Val/Val, corrected, P,0.05). cMFC, caudal middle
frontal cortex; IC, insular cortex; IPC, inferior parietal cortex; LOC, lateral occipital cortex; MTC, middle temporal cortex; OFC, orbital frontal cortex; PC,
precuneus cortex; PCC, posterior cingulate cortex; rMFC, rostral middle frontal cortex; SFC, superior frontal cortex; SPC, superior parietal cortex;. See
Table 2 and Table 3 for details.
doi:10.1371/journal.pone.0037777.g001
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was demonstracted indirectly by an animal study in which the
Met/Met genotype could cause a most significant decrease in the
regulated secretion of BDNF by 30% (Val/Met by 18%) [5],
where secreted BDNF is known to regulate neuronal development
and differentiation. Therefore, extensive decreased GM in Met
homozygotes may account for by serious altered neuronal
morphology in the present study.
The findings of some previous studies reporting smaller
hippocampal volume in Met allele carriers were not replicated
in either of our Val/Met or Met/Met subjects. However, our
negative results were consistent with several recent reports, in
which no evidence for an influence of the BDNF Val66Met
genotype on MRI-derived reduced hippocampus volume was
found [8,38,39,40]. One reason for these conflicting results may be
due to the fact that our study focused on the Chinese population,
unlike previous positive studies [6,7]; however, the genetic effect of
BDNF Val66Met polymorphism on hippocampal morphology
remains controversial and requires further investigation.
Another point of note is the influence of the grouping method
on our results. When we merged the Met/Met and Val/Met
groups to obtain the Met carriers group in the VBM analysis, as
performed in previous studies [6,8,11,31], the reduction in GM
values in brain areas was much smaller in the Met carriers than in
the Met/Met group. These results suggested that grouping method
of Met carriers may hide some specific roles of Met/Met in brain
morphology. To date, we do not know if such a marked
discrepancy caused by grouping method also exists in similar
analyses based on the Caucasian race because of the low frequency
of Met/Met in Caucasians. Nevertheless, our present study has
Table 2. Areas with decreased cortical thickness in the Met/Met group compared with the Val/Val group based on the BDNF
Val66Met polymorphism (FDR corrected, P,0.05).
Brain area Side Talariach coordinate Size-mm
2 Max
a
xy z
Superior frontal cortex Left 22.37 61.6 4.7 2202.95 22.38
Left 28.3 52.2 36.7 271.38 22.17
Left 211.3 5.2 39.1 11.0 21.37
Rostral middle frontal cortex Left 238.5 40.2 17.8 26.40 –1.37
Left 234.9 33.9 10.4 32.09 21.43
Caudal middle frontal cortex Left 243.1 21.4 32.8 20.57 21.53
Orbitofrontal cortex Left 28.8 31.5 221.3 53.68 21.75
Left 223.3 42.2 210.7 80.20 21.67
Superior parietal cortex Left 222.8 248.1 58.1 236.11 22.68
Left 28.7 264.0 55.0 75.65 21.56
Left 233.5 268.3 43.9 23.72 21.48
Inferior parietal cortex Left 233.5 268.3 43.9 23.72 21.48
Middle temporal cortex Left 249.1 235.0 28.4 68.74 22.27
Left 253.9 213.2 224.9 22.81 21.46
Posterior cingulate cortex Left 24.9 233.7 38.7 13.03 21.54
Lateral occipital cortex Left 225.9 296.2 214.6 56.22 21.59
Left 237.6 285.6 215.3 27.26 21.53
Precuneus cortex Left 210.4 245.7 48.9 35.26 21.45
Insular cortex Left 238.0 224.1 20.6 94.32 22.82
Left 233.3 221.6 10.4 34.41 21.54
Superior frontal cortex Right 8.7 48.7 17.7 119.56 22.01
Rostral middle frontal cortex Right 34.8 48.6 14.3 260.90 24.00
Right 41.5 23.1 27.2 29.36 21.45
Right 22.9 53.6 15.2 30.18 21.89
Right 45.3 32.0 22.0 29.56 21.42
Caudal middle frontal cortex Right 32.7 16.9 47.7 138.38 23.11
Orbitofrontal cortex Right 7.5 14.0 215.9 303.89 22.50
Right 10.8 49.5 210.4 180.46 22.49
Right 13.8 39.5 224.2 232.69 23.05
Superior parietal cortex Right 22.2 261.2 50.4 25.32 21.50
Right 32.6 245.7 44.0 11.52 21.42
Lateral occipital cortex Right 43.8 280.9 27.9 21.10 21.48
Precuneus cortex Right 6.0 262.5 55.3 89.81 22.85
doi:10.1371/journal.pone.0037777.t002
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Val66Met polymorphism (FDR corrected, P,0.05).
Brain area Side Talariach coordinate Size-mm
2 Max
a
xyz
Superior frontal cortex Left 221.8 21.5 55.8 416.98 22.97
Rostral middle frontal cortex Left 243.5 22.0 32.5 20.77 21.76
Left 240.9 38.1 22.9 15.01 21.39
Orbitofrontal cortex Left 222.2 43.5 212.7 56.96 21.57
Left 26.4 28.9 218.1 46.48 21.55
Superior parietal cortex Left 224.7 248.3 59.0 289.68 22.35
Left 29.9 262.2 55.2 306.25 22.19
Left 228.9 248.4 40.6 29.69 21.67
Middle temporal cortex Left 250.0 238.3 26.8 67.79 21.68
Left 257.4 222.1 220.3 82.84 22.00
Lateral occipital cortex Left 237.8 283.5 2.1 97.11 21.89
Left 29.8 2102.1 4.1 104.15 21.88
Insular cortex Left 231.9 228.4 9.4 21.99 21.64
Left 235.5 212.3 7.6 266.69 22.20
Rostral middle frontal cortex Right 35.8 51.5 24.4 57.83 21.54
Right 35.7 48.7 16.1 137.93 23.02
Right 22.8 52.4 16.2 137.47 22.49
Caudal middle frontal cortex Right 33.4 15.5 49.5 117.14 22.62
Orbitofrontal cortex Right 13.0 44.2 223.7 237.25 22.88
Superior parietal cortex Right 19.7 241.6 60.8 43.65 21.74
Right 33.5 246.6 62.7 28.31 21.56
Right 32.3 243.7 48.4 28.03 21.44
Right 9.9 273.3 44.5 389.99 22.98
Middle temporal cortex Right 47.9 261.5 4.5 12.65 21.54
Precuneus cortex Right 6.4 261.5 56.5 145.21 22.59
Insular cortex Right 37.4 3.0 215.9 118.57 21.97
doi:10.1371/journal.pone.0037777.t003
Figure 2. VBM differences among three genotypes based on the BDNF Val66Met polymorphism. Top panel: areas with a significantly
decreased GM volume in Met/Met group compared with Val/Val group (Met/Met , Val/Val, corrected, P,0.05). Bottom left panel: areas with a
significantly decreased GM volume in the Val/Met group compared with the Val/Val group (Val/Met , Val/Val, corrected, P,0.05). Bottom left panel:
areas with a significantly decreased GM volume in the Met carriers group (Met/Met+Val/Met) compared with the Val/Val group (Met carriers , Val/
Val, corrected, P,0.05 ). ACC, anterior cingulate cortex; MCC, middle cingulated cortex; MTC, middle temporal cortex; IC, insular cortex; IFC, inferior
frontal cortex; OFC, orbital frontal cortex; PCC, posterior cingulate cortex; STC, superior temporal cortex.
doi:10.1371/journal.pone.0037777.g002
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genotype cannot be represented entirely by a general group of Met
carriers. The current findings indicated that availability of a large
sample size that can be divided into three genotypes is helpful in
clarifying the effect of BDNF Val66Met polymorphism, which
should be given more attention in future studies.
Study Limitations
There are some limitations to our work. The first one is that we
didn’t measure the behavioral differences in cognition, emotion,
memory and other factors among BDNF Val66Met genotypes.
These behaviors related to higher brain function have often been
shown to be affected by BDNF Val66Met polymorphism [4,8,41].
Thus, if the genetic impact on brain structure in the current study
could correlate to behaviors that were close to BDNF function, this
would contribute greatly to inferences regarding structural brain
differences determined by BDNF Val66Met polymorphism. The
second limitation of this study is the small sample size. There were
only 15 and 17 individuals in the Met/Met and Val/Val groups
respecitvely, which is relatively small for an objective result. Larger
sample sizes are required for futher related studies. The third
limitation was this study was that comparisons of brain morphol-
ogy were only carried out at one time-points. To obtain more data,
brain morphology data should be collected at two different time –
points. These limitations need to be addressed in future related
studies.
Conclusion
In conclusion, the current study demonstrates brain morphol-
ogy differences related to BNDF Val66Met polymorphism
(especially the Met/Met genotype) for the first time in healthy
young Chinese adults using a dual analytical method, via cortical
thickness analysis and VBM. Unlike Caucasians with significant
brain structural differences in Val/Met genotype individuals,
Chinese brain anatomy varied mostly in the Met/Met genotype
with less GM mainly in the frontal, temporal, cingulate and insular
cortices. In addition, by way of analyzing Met carriers, the present
study suggested that combining Val/Met and Met/Met genotypes
as Met carriers would probably mask the unique role of the Met/
Met genotype on brain morphology, which should be taken into
account in future studies.
Materials and Methods
The research procedures were approved by the West China
Hospital Subcommittee on Human Studies and were conducted in
accordance with the Declaration of Helsinki. All participants were
recruited by advertisement, and and gave their written informed
consent after they were fully explained the experimental procedure
ahead of the experiment. The corresponding content was
approved by the West China Hospital Subcommittee.
Subjects
The data included in this study were drawn from 81 healthy,
right-handed Chinese college students (mean age: 20.560.88
years, range: 19–23; 48 males). For all subjects, exclusion criteria
were: 1) reported history of brain injury; 2) macroscopic brain T2-
visible lesions, tumor or obvious cortical/subcortical atrophy on
MRI scans; 3) psychiatric disorders evaluated by the Structured
Clinical Interviews for DSM-IV Axis I (SCID-I) and Axis II
(SCID-II); 4) existence of a neurological disease diagnosed by
clinical neurological examination; 5) pregnancy or menstrual
period; 6) use of prescription medications within the last month; 7)
alcohol, nicotine or drug abuse; 8) dementia. Therer were no
differences in IQ among genotype groups according to the
Chinese Revised Wechsler Adult Intelligence Scale (WAIS-RC).
Genotyping
Genomic DNA was isolated from 500 ml of whole blood using
TIANamp genomic DNA kit according to the manufacturer’s
instructions (TIANGEN BIOTECH CO., LTD., Beijing, China).
Polymerase chain reaction (PCR) was carried out in a volume of
20 mLcontaining 10 ng of genomic DNA, 2.5 mLo f1 0 6Taq
buffer, 2 mL of dNTP Mixture (2.5 mM), 0.5 mL of Taq DNA
Polymerase (2.5 U/mL, TIANGEN BIOTECH CO., LTD.,),
1 mL of each primer and ddH2O. The PCRs were done using a
BIO-RAD cycler system. The primers were as follows: 59-
AAACATCCGAGGACAAGGTG-39 (forward), 59-AGAAGAG-
GAGGCTCCA AA GG-39 (reverse). The amplification conditions
were initiated at 94uC for 5 min, followed by 30 cycles consisting
of denaturation at 94uC for 30 s, annealing at 65uC for 30 s and
extension at 72uC for 30 s, with a final extension step of 5 min at
72uC. The PCR products were confirmed by 2% (w/v) gel
electrophoresis and purified using the TIANgel Midi purification
kit (TIANGEN BIOTECH CO., LTD.). BDNF gene sequence
was implemented in Shanghai Bio-tech Co., Ltd. (Shanghai,
China). Genotypes of the BDNF Val66Met polymorphism were
read by at least two researchers who were blinded to the
experiment. For genotypic distribution analysis, the Hardy–
Weinberg Equilibrium was tested by the goodness-of-fit x
2 test.
Structural MRI Acquisition
The MRI experiment was performed using a 3.0 Tesla MRI
scanner (Magnetom Trio, Siemens) with a standard head coil. A
set of T1-weighted high-resolution structural images was collected
(TR/TE: 2.7 s/3.39 ms, FOV: 256 mm6256 mm, matrix size:
2566256, flip angle: 12u, in-plane resolution: 1 mm61 mm, slice
thickness: 1 mm with no gaps).
Cortical Thickness Processing
FreeSurfer 5.0 (http://surfer.nmr.mgh.harvard.edu/) was em-
ployed to calculate the cortical thickness from the structural MRI
according to the detailed procedures in previous studies
[42,43,44]. Local cortical thickness was measured on the basis of
the difference between the position of equivalent vertices in the
pial and gray-white matter surfaces. In brief, cerebral white matter
was segmented from the T1-weighted images and the gray-white
matter interface was estimated [43]. Topographical defects in the
gray-white estimate were fixed, which were then used as the
starting point for the deformable surface algorithm search for the
pial surface. The surface of the gray-white matter border was
inflated, and differences between subjects in the depth of the gyri
and sulci were normalized. The reconstructed brain of each
subject was deformed and registered to an average spherical
surface [44]. To obtain cortical thickness difference maps, the data
were smoothed on the surface with a Gaussian smoothing kernel
with a full-width half maximum of 10 mm. Statistical thickness
difference maps were constructed with t statistics (with the
inclusion of age and gender as covariates) with a threshold of
P,0.05 ((false discovery rate (FDR) corrected)).
VBM Processsing
Structural data was analysed with FSL-VBM, a voxel-based
morphometry style analysis [45,46] carried out with FSL tools
[46]. Structural data were analyzed using FSL-VBM, a voxel-
based morphometry style anslysis [45,46], which was carried out
with FSL tools [47]. The structural images were first brain-
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PLoS ONE | www.plosone.org 6 June 2012 | Volume 7 | Issue 6 | e37777extracted using BET [48]. Then, the resulting gray matter partial
volume images were aligned to MNI152 standard space using the
nonlinear registration tool FNIRT, which uses a b-spline
representation of the registration warp field. The registered
images were averaged to create a study-specific template, to
which the native gray matter images were then non-linearly re-
registered. The registered images were then modulated (to correct
for local expansion or contraction) by dividing by the Jacobian of
the warp field. The modulated segmented images were then
smoothed with an isotropic Gaussian kernel with a sigma of 3 mm.
Finally, group-difference in gray matter volume was tested using
permutation-based non-parametric testing (10,000 permutations)
with gender and age included as covariates. Multiple comparisons
across space were corrected using the threshold-free cluster
enhancement method [49]. A difference was considered to be
significant at a corrected P,0.05. The minimal number voxels
was 8.
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